SC Filed 2022-07-11 Event — SEC 0001829126-22-014252 →

Lazar David E. → EQUUS TOTAL RETURN, INC. EQS

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 32/100 · Filer 90d Win Rate: 67% · Hist. 90d Edge: +132.4%

Filer track record (4 filings): 67% 90d win rate, +132.4% 90d edge
Short interest building (+219.1% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 2.18

23,302 shares short · +219.1% vs prior

Other 13D/G Filings on EQUUS TOTAL RETURN, INC.

Filed	Form	Filer	Stake	Shares
2026-06-23	SCHEDULE 13D	Horberg Howard Todd	5.61%	783,000	view →
2021-10-18	SC	des Pallieres Bertrand	—	—	view →
2020-07-20	SC	MVC CAPITAL, INC.	—	—	view →
2019-08-13	SC	MVC CAPITAL, INC.	—	—	view →
2019-07-31	SC	MVC CAPITAL, INC.	—	—	view →

Other Filings by Lazar David E.

Filed	Form	Issuer	Stake	Shares
2026-09-29	SCHEDULE 13D/A	Aterian, Inc.	3.10%	8,038,030	view →
2026-09-10	SCHEDULE 13D	Aterian, Inc.	95.70%	249,900,000	view →
2026-08-07	SCHEDULE 13D/A	Quantum Cyber N.V.	94.30%	477,000,000	view →
2026-07-02	SCHEDULE 13D/A	KALA BIO, Inc. KALA	3.90%	719,404	view →
2026-04-28	SCHEDULE 13D	MAINZ BIOMED N.V. QUCY	97.40%	477,000,000	view →
2026-01-29	SCHEDULE	NovaBay Pharmaceuticals, Inc. SDEV	4.99%	6,388,000	view →
2025-03-10	SCHEDULE	FiEE, Inc. FIEE	35.10%	2,802,254	view →
2024-04-08	SC	OPGEN INC CFOR	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →